Medical Billing · Nationwide
Cytoreductive Prostatectomy & High-Risk Robotic Urologic Oncology Medical Billing Services
Robot-assisted radical prostatectomy (RARP) with extended pelvic lymph node dissection (ePLND), retroperitoneal robotic partial nephrectomy with warm ischemia preservation, and robot-assisted radical cystectomy (RARC) with intracorporeal urinary diversion (neobladder/ileal conduit): robotic assistance defense, extended lymphadenectomy unbundling, and complex reconstructive coding.
Aethera Healthcare Solutions provides full-service medical billing and revenue cycle management to urologic oncologists, robotic urologic surgeons, minimally invasive pelvic reconstructive teams, and comprehensive cancer centers across the United States. We handle coding, claims, payment posting, denial management, and A/R follow-up end to end — so your team can stay focused on patient care while your revenue cycle runs cleanly.
Typical cytoreductive prostatectomy & high-risk robotic urologic oncology CPT range we work: 55866, 38571, 38572, 50543, 50545, 51596, 50825, 49320, 50845, 99214, 99223.
Why cytoreductive prostatectomy & high-risk robotic urologic oncology billing leaks revenue
Extended pelvic lymphadenectomy (+38571/+38572) unbundling denials: Payers bundling extensive bilateral pelvic lymph node dissection into robotic radical prostatectomy (55866) despite retroperitoneal nodal clearance above the bifurcation of the common iliac vessels
Robotic instrumentation S-code denials (S2900): Commercial payers rejecting robotic surgical technique add-on codes or downcoding robotic partial nephrectomy (50543) based on software/hardware supply bundling
Intracorporeal urinary diversion bundling in robotic radical cystectomy (51596): Payers rejecting robot-assisted complete intracorporeal orthotopic neobladder or ileal conduit diversion (50825) as inclusive to cystectomy
Renal hypothermia and complex hilar reconstruction clawbacks: Disallowing Modifier -22 for prolonged warm ischemia control, tumor enucleoresection, and renorrhaphy in endophytic complex renal tumors (PADUA/RENAL score >10)
How Aethera fixes it
Specialty-trained coders (CPC/CCS) code to the documentation
First-pass claim scrubbing against payer and NCCI edits
Proactive denial prevention and 72-hour denial work
Relentless A/R follow-up to drive days-in-A/R down
Eligibility and prior-auth verification before service
Transparent, real-time reporting in the provider portal
Free tools for your billing team
Use these any time — no login required.
Cytoreductive Prostatectomy & High-Risk Robotic Urologic Oncology billing FAQ
When is pelvic lymphadenectomy (38571/38572) separately billable with robotic radical prostatectomy (55866)?
Under CPT coding definitions, CPT 55866 includes standard staging pelvic lymphadenectomy limited to obturator nodes. When an extended pelvic lymph node dissection (ePLND) is performed for high-risk or locally advanced prostate cancer—extending to the external iliac, hypogastric, and common iliac nodal packets up to the aortic bifurcation—CPT 38572 (laparoscopy, surgical; with bilateral total pelvic lymphadenectomy and periaortic lymph node sampling) is separately billable with Modifier -59 or -XU, supported by pathology logs demonstrating separate nodal packets.
How should surgical teams document Modifier -22 on complex robotic partial nephrectomy (50543)?
When an endophytic, central, or hilar renal tumor requires prolonged warm ischemia, multiple intraoperative ultrasound assessments, complex vascular control, and double-layer renorrhaphy, Modifier -22 (increased procedural services) should be appended to CPT 50543. The operative note must include a dedicated "Modifier 22 Justification" paragraph documenting specific percentage increases in operative time, blood loss, and technical complexity beyond standard partial nephrectomy.